Xiao C. Li et al. showed that increased NHE3 was associated with hypertension and revealed that the NHE3 inhibitor reduced angiotensin II (Ang II)-induced hypertension in PT-Nhe3−/− mice, implying the regulatory effect of Ang II on NHE3 [113]. Here, SLC9A3 is linked to hypertensive disorder.